Cyclic and linear bradykinin analogues: implications for B2 antagonist design

Area of Science:

• Pharmacology
• Medicinal Chemistry
• Biochemistry

Background:

• Bradykinin (BK) antagonists show therapeutic potential for inflammation, pain, and trauma.
• Understanding the structure-activity relationships of BK analogues is crucial for developing effective antagonists.

Purpose of the Study:

• To identify chemical features promoting effective BK antagonism.
• To explore the impact of structural modifications on BK analogue folding and receptor interactions.

Main Methods:

• Synthesis of BK analogues with constrained, proteolytic-resistant residues (Bip, Dip, 2Ind) at positions 1 and 7.
• Comparison of cyclo(3,8) vs. cyclo(5,8) BK analogues to assess folding effects.
• Evaluation of agonistic and antagonistic activities using guinea pig ileum, rat uterus, and depressor assays.

Main Results:

• Co-planarity of the residue-7 side chain with its backbone NH is vital for both agonism and antagonism.
• A D-directed side chain at position 7 is critical for antagonism.
• Residue-1 modifications influence activity: L-orientation is important, Dip1 promotes agonism, and Bip1 promotes inhibition.
• Ileal and uterine receptors exhibit distinct preferences for BK conformations.

Conclusions:

• Specific structural modifications, including side chain orientation and cyclization, can significantly enhance BK antagonist potency.
• Ileal receptors favor BK conformations with proximal residues 3 and 8, distinct from residue 5, for improved antagonism (pA2).
• The study provides insights into designing targeted BK antagonists by understanding receptor-specific conformational preferences.